Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 73

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 12
Chunk 73
---
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

Securities Authorized for Issuance under Equity Compensation Plans

Securities authorized for issuance under our equity compensation plans as of December 31, 2024 are as follows: 

PlanCategory1Number of securities to beissued upon exercise ofoutstanding options, warrants and rights2 (a)Weighted-averageexercise price ofoutstanding options, warrants and rights3 (b)Number of securitiesremaining available forfuture issuance under equitycompensation plans (excluding securities reflected in column (a))4 (c)Equity compensation plans approved by shareholders as of December 31, 20244,415,217$361.3614,215,732

1We have no equity compensation plans pursuant to which awards may be granted in the future that have not been approved by shareholders.

 -137-

2Includes shares that may be issued under the Elevance Health Incentive Compensation Plan and the 2017 Elevance Health Incentive Compensation Plan pursuant to the following outstanding awards: 2,863,293 stock options, 500,096 unvested restricted stock units, and 1,051,828 performance stock units (assuming that the outstanding performance stock units are earned at the maximum award level). 

3Represents the weighted average exercise price of outstanding stock options. Does not take into consideration outstanding restricted stock units or performance stock units, which, once vested, may be converted into shares of our common stock on a one-for-one basis upon distribution at no additional cost.

4Excludes securities reflected in the first column, “Number of securities to be issued upon exercise of outstanding options, warrants and rights.” Includes 10,204,347 shares of common stock available for issuance as stock options, restricted stock awards, performance stock awards, performance awards and stock appreciation rights under the 2017 Elevance Health Incentive Compensation Plan at December 31, 2024. Includes 4,011,385 shares of common stock available for issuance under the Stock Purchase Plan at December 31, 2024. 

 The information required by this Item concerning the stock ownership of management and five percent beneficial owners is incorporated herein by reference from our definitive Proxy Statement for our 2025 Annual Meeting of Shareholders, which will be filed with the SEC pursuant to Regulation 14A within 120 days after the end of our last